Roche Pharmaceuticals - Business Overview

pha_overview_740px

Roche Pharma at a glance:

  • Focused on translating excellence in science into breakthrough medicines for patients
  • One of the leading developers of targeted treatments combined with corresponding diagnostics
  • The world’s largest biotech company
  • The world’s leading provider of cancer treatments

Roche Pharmaceuticals – Business overview

Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients. It combines cutting-edge research at Roche, Genentech in the US, Chugai in Japan and over 150 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations. Thanks to the Pharmaceuticals Division’s broad-based portfolio, Roche is one of the world’s leading providers of clinically differentiated medicines.

Focus on innovation

Roche Pharmaceuticals is living proof that scientific invention leads to products that truly save and improve patients’ lives. Roche’s inspiring tradition of excellence in science dates back more than a century. Today, as then, our strategy is rooted in fostering excellence in science and empowering scientists to create breakthroughs in life science that will make a difference tomorrow.

Focusing on oncology, immunology, ophthalmology, infectious diseases and neuroscience, we firmly believe in the tremendous potential to translate science into therapies which reduce human suffering and help people live longer and healthier lives.

The world's leading biotech company

In our pursuit of excellence in science, our distinctiveness rests on four key elements: an exceptionally broad and deep understanding of molecular biology, the seamless integration of our pharmaceuticals and diagnostics capabilities, a diversity of approaches to maximise innovation, and a long-term orientation.

The world’s leading provider of cancer treatments

Cancer remains the second leading cause of death in the industrialised world and its incidence is growing. But if detected early enough, many forms of the disease can be effectively treated. We have been at the forefront of cancer research and treatment for over 50 years. Our medicines treat breast, skin, colon, ovarian, lung and numerous other cancers. Roche currently has a number of innovative cancer drugs on the market. They give patients the most important thing in life: time to live.

Contribution to sustainable healthcare

Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines. By developing products that advance the standard of care for diseases with significant unmet need we are able to meet our obligations not only to shareholders but to society as a whole.